(Source: tuoitre.vn)Hanoi (VNA) – The on September 10 issued a
decision on conditionally approving the Hayat-Vax vaccine for emergency use
in COVID-19 prevention and control, making it the seventh vaccine obtaining a licence
for emergency use in Vietnam.
Accordingly, the Hayat – Vax vaccine is semi-finished by the
Beijing Institute of Biological Products Co., Ltd. of China National Biotec
Group Company Limited (CNBG).
This vaccine is packaged and delivered from Julphar (Gulf
Pharmaceutical Industries) of the United Arab Emirates (UAE).
In Vietnam, Vimedimex Pharmaceutical Joint Stock Company had
proposed for the approval of this vaccine.
Hayat-Vax is an inactivated vaccine, produced by
growing the SARS-CoV-2 in cell culture and then using chemicals to inactivate
the virus.
The ministry asked the Drug Administration of Vietnam to
license the import of the vaccine and abide by regulations on the management of
import and the quality of imported vaccines.
Meanwhile, the Administration of Science Technology and
Training will select and guide qualified units to assess the vaccine’s safety
and efficacy based on advice from the advisory council on use of vaccines and
biologicals.
The General Department of Preventive Medicine is responsible
for conducting vaccination using Hayat-Vax. The ministry also assigned the
National Institute for Control of Vaccine and Biologicals to conduct checks and
grant certificates for batches of the vaccine before use.
At present, there are seven foreign COVID-19 vaccines that
have obtained a license for in Vietnam, namely AstraZeneca by AstraZeneca, Vero Cell by China National Biotec Group (CNBG)/Sinopharm, Sputnik V, Pfizer,
Moderna and Johnson & Johnson, and Hayat-Vax./.
Source: VietnamPlus
